Diabetes is not only a metabolic disorder; it is also an important cardiovascular risk condition. People with diabetes have a higher risk of cardiovascular disease and heart failure, and diabetes can contribute to changes in myocardial structure and function. The American Diabetes Association (ADA) 2026 Standards of Care notes that heart failure is at least twice as prevalent in people with diabetes compared with those without diabetes.
For doctors, understanding diabetic heart disease means looking beyond coronary artery disease. It also involves recognizing the relationship between diabetes, diabetic cardiomyopathy, myocardial dysfunction and heart failure, while considering other factors such as hypertension, obesity, chronic kidney disease and dyslipidemia.
What Is Diabetic Heart Disease?
Diabetic heart disease is a broad term describing cardiovascular conditions associated with diabetes. These can include coronary artery disease, heart failure and diabetes-associated myocardial dysfunction.
One important concept within this spectrum is diabetic cardiomyopathy. It refers to structural or functional abnormalities of the myocardium associated with diabetes. However, the definition continues to evolve because diabetes frequently occurs alongside other cardiovascular risk factors. The European Society of Cardiology has emphasized that diabetes-associated myocardial dysfunction commonly occurs together with conditions such as obesity, hypertension, chronic kidney disease and coronary artery disease.
How Does Diabetes Affect the Heart?
Several mechanisms can contribute to cardiovascular and myocardial changes in diabetes:
- Chronic hyperglycemia: Persistent high blood glucose can contribute to oxidative stress, inflammation and advanced glycation-related changes.
- Insulin resistance: Altered insulin signaling can affect myocardial energy metabolism.
- Metabolic dysfunction: Changes in how the heart uses glucose and fatty acids can affect cardiomyocyte function.
- Microvascular dysfunction: Diabetes can impair vascular and endothelial function.
- Myocardial fibrosis: Metabolic and inflammatory changes can contribute to fibrosis and cardiac remodeling.
- Autonomic dysfunction: Diabetic autonomic neuropathy can affect cardiovascular regulation.
Read more: Cardiovascular complications of diabetes
What Is Diabetic Cardiomyopathy?
Diabetic cardiomyopathy describes diabetes-associated myocardial structural and functional abnormalities that can contribute to progressive cardiac dysfunction.
Early changes may include:
- Diastolic dysfunction
- Increased myocardial stiffness
- Cardiac remodeling
- Myocardial fibrosis
- Ventricular hypertrophy
As disease progresses, systolic dysfunction and clinical heart failure may develop. Recent reviews describe diabetic cardiomyopathy as a potential pathway from early, often clinically subtle myocardial abnormalities to symptomatic heart failure.
Diabetes and Heart Failure: What Is the Connection?
The relationship between diabetes and heart failure is clinically important. The ADA recognizes diabetes as a major risk factor for incident heart failure and notes that people with diabetes can develop different heart-failure phenotypes, including HFpEF, HFmrEF and HFrEF.
Diabetes may contribute to heart failure through several pathways, including:
- Coronary artery disease
- Hypertension
- Obesity
- Chronic kidney disease
- Insulin resistance
- Myocardial metabolic abnormalities
- Cardiac remodeling and fibrosis
Can diabetes cause heart failure?
Yes. Diabetes is an established risk factor for heart failure. The pathway may involve coronary disease or hypertension, but diabetes-associated myocardial dysfunction can also contribute to heart failure.
This is why diabetes and heart failure should be considered interconnected clinical conditions rather than completely separate problems.
Congestive Heart Failure and Diabetes: What Should Doctors Consider?
When congestive heart failure and diabetes occur together, clinicians may need to consider several overlapping cardiovascular, metabolic and renal factors.
Relevant considerations include:
- Cardiovascular risk profile
- Blood pressure and lipid status
- Kidney function
- Glycemic control
- Obesity and other metabolic factors
- Symptoms and signs of heart failure
- Existing coronary artery disease
- Heart-failure phenotype
The clinical approach should be individualized to the patient’s presentation and current guidelines, not based on diabetes status alone.
How Can Doctors Assess Diabetic Heart Disease?
There is no single test that independently identifies every case of diabetic heart disease or diabetic cardiomyopathy. Assessment generally combines clinical history, cardiovascular risk evaluation and appropriate investigations.
ECG
An ECG can help identify rhythm, conduction or other abnormalities that may warrant further evaluation.
Echocardiography
Echocardiography can assess cardiac structure and function, including ventricular function and features of diastolic dysfunction.
BNP and NT-proBNP
Natriuretic peptides can help identify patients at increased risk of heart failure or support evaluation when heart failure is suspected. The ADA 2026 Standards recommend considering natriuretic peptide measurement in appropriate adults with diabetes to help identify risk of progression to symptomatic heart failure.
Additional imaging
Cardiac MRI and advanced echocardiographic techniques are increasingly relevant to the assessment and research of myocardial structure, fibrosis and early dysfunction.
The choice of investigation should depend on the patient’s symptoms, risk profile and clinical context.
Cardiovascular Risk Factors Doctors Should Assess in Diabetes
Diabetic heart disease rarely exists in isolation. Doctors should consider the combined effect of:
- Hypertension
- Dyslipidemia
- Obesity
- Chronic kidney disease
- Smoking
- Physical inactivity
- Duration and control of diabetes
- Established cardiovascular disease
This broader assessment is important because cardiovascular risk in diabetes is influenced by multiple interacting factors rather than blood glucose alone.
What Is Changing in Diabetic Cardiomyopathy Research?
Current research is examining several areas that may improve earlier detection and treatment of diabetic cardiomyopathy, including:
- Biomarkers of myocardial injury and fibrosis
- Advanced cardiac imaging
- Myocardial metabolic pathways
- Oxidative stress and inflammation
- SGLT2 inhibitors
- GLP-1 receptor agonists
- Finerenone
- Novel approaches to myocardial fibrosis and remodeling
SGLT2 inhibitors and other guideline-directed cardiovascular therapies have an established role in managing cardiovascular risk and heart failure in people with diabetes. However, there is no single treatment specifically approved or established for diabetic cardiomyopathy as a distinct condition.
What Should MBBS Doctors Know About Diabetic Heart Disease?
For MBBS doctors and clinicians managing patients with diabetes, several principles are particularly relevant:
- Diabetes should be considered a cardiovascular risk condition, not only a metabolic disorder.
- Heart failure can occur in people with diabetes, including patients without known coronary artery disease.
- Early myocardial dysfunction may be clinically subtle.
- Hypertension, obesity, dyslipidemia and kidney disease can significantly modify cardiovascular risk.
- ECG, natriuretic peptides and echocardiography may have important roles in appropriate clinical settings.
- Cardiovascular and diabetes care increasingly overlap and may require multidisciplinary management.
- Current evidence and guidelines continue to evolve.
Continuing Education for Doctors
Managing diabetic heart disease requires an understanding of how diabetes, cardiovascular risk, myocardial dysfunction and heart failure can overlap in clinical practice. As evidence and treatment approaches continue to evolve, structured continuing medical education can help doctors strengthen their knowledge in specific areas of patient care.
For doctors interested in developing their knowledge of cardiovascular assessment and management, Medigrad’s Fellowship in Cardiology provides a structured learning pathway focused on cardiovascular medicine, subject to the program’s eligibility and curriculum requirements.
For doctors whose clinical interests center more specifically on diabetes, glycemic management and diabetes-related complications, a Fellowship in Diabetology may provide relevant focused education.
These programs are intended for professional learning and are not a substitute for an MD, MS or DNB qualification. Doctors should select further education based on their existing qualifications, scope of practice, clinical interests and learning objectives.
Frequently Asked Questions
Is diabetic heart disease the same as diabetic cardiomyopathy?
No. Diabetic heart disease is a broader term that can include coronary artery disease, heart failure and diabetes-associated myocardial dysfunction. Diabetic cardiomyopathy refers more specifically to structural or functional abnormalities of the heart muscle associated with diabetes.
How does diabetes increase the risk of heart failure?
Diabetes can contribute to heart failure through several interacting mechanisms, including metabolic abnormalities, hypertension, coronary artery disease, kidney disease, myocardial fibrosis and cardiac remodeling. Diabetes is also an established risk factor for developing heart failure.
What are the early cardiac changes associated with diabetes?
Early changes may occur before obvious symptoms of heart failure and can include diastolic dysfunction, increased myocardial stiffness, subtle ventricular dysfunction, remodeling and myocardial fibrosis. These abnormalities may require appropriate cardiac assessment to identify.
How is diabetic cardiomyopathy evaluated?
There is no single test that confirms diabetic cardiomyopathy in every patient. Evaluation may involve clinical assessment, ECG, echocardiography and, when appropriate, natriuretic peptides such as BNP or NT-proBNP. Cardiac MRI and advanced imaging techniques may provide additional information in selected cases.
Which heart failure types can occur in people with diabetes?
People with diabetes can develop different heart failure phenotypes, including heart failure with preserved ejection fraction (HFpEF), mildly reduced ejection fraction (HFmrEF) and reduced ejection fraction (HFrEF). The underlying causes and clinical management can differ between patients.
What cardiovascular risk factors should doctors assess in patients with diabetes?
Assessment should consider more than glycemic control. Relevant factors include blood pressure, lipid status, obesity, kidney function, smoking, physical activity, diabetes duration and established cardiovascular disease.
